NCLT approves amalgamation of Vitanosh Ingredients into Lactose India

Scheme filed with the NCLTStrategic Transactions View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+5.0%Reaction day

₹101.00

prior close

₹103.85

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-2.6%+7.6% vs market

Pharmaceuticals peers, median of 172sector-1.7%+6.6% vs sector

On the reaction day the stock moved 7.6 pts more than Nifty Microcap 250 and 6.6 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+5.0-2.6+7.6-1.7+6.6

Next day

-1.5-3.6+2.1-2.2+0.7

-1.5-5.8+4.4-3.5+2.0

+3.0-5.5+8.4-2.4+5.4

+0.0-3.8+3.8-1.2+1.2

+5.9-3.8+9.7+0.1+5.9

+8.9-5.6+14.5-1.3+10.2

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

NCLT Ahmedabad approved amalgamation of Vitanosh Ingredients Pvt Ltd into Lactose India Ltd via order dated August 5, 2026. Board fixed November 2, 2026 as Record Date to identify VIPL shareholders entitled to LIL shares. Exchange ratio fixed at 0.7946 LIL equity shares for every 1 VIPL share held. LIL will allot fresh equity shares of INR 10 face value to qualifying VIPL shareholders.

Likely market impact

Existing LIL shareholders face dilution as new shares are issued to VIPL shareholders per the swap ratio. Watch price action near the Record Date.